Both in Pharmaceuticals
Faeth Therapeutics vs Monopar Therapeutics
Over the past year FTH returned −50.1% and MNPR returned −36.2%; their daily moves had a correlation of 0.33.
FTH −50.1% MNPR −36.2%Growth of $1, one year, split-adjusted
| Metric | FTH | MNPR |
|---|---|---|
| Price | $18.69 | $70.32 |
| Market cap | $483.0M | $472.0M |
| Today | −0.32% | −2.21% |
| 1 month | −33.9% | −9.8% |
| 6 months | — | +32.1% |
| Year to date | — | +7.7% |
| 1 year | — | −16.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $186.4M | $134.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 49.1% |
| Short % of float | 16.6% | 23.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).